ENRIGHT PATRICK G — SEC Form 4 filings
SEC reporting owner CIK 1253886. 20 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2024-05-17 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 11 legs across 6 filings — 2,288,137 shares, $40,732,323 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 2 filings — 157,739 shares, $663,949 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: purchase of 882,353 shares @ $17.00 ($15,000,001) in Veradermics, Inc, filed 2026-02-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Veradermics, Inc (MANE) | Director, 10% owner | 1 | 2 legs · 1,075,000 sh · $18,275,000 | — | 7 |
| Zenas BioPharma, Inc. (ZBIO) | Director | 4 | 3 legs · 557,255 sh · $9,730,026 | — | 9 |
| BioAge Labs, Inc. (BIOA) | Director | 3 | 1 leg · 400,000 sh · $7,200,000 | — | 5 |
| Vera Therapeutics, Inc. (VERA) | Director | 5 | 5 legs · 255,882 sh · $5,527,296 | — | 3 |
| RAPID MICRO BIOSYSTEMS, INC. (RPID) | 10% owner | 2 | — | 5 legs · 157,739 sh · $663,949 | 3 |
| Jazz Pharmaceuticals plc (JAZZ) | Director | 5 | — | — | 7 |
Form 4 filings — ENRIGHT PATRICK G
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 14 @ $244.64 · Tax withholding (F): 1,692 @ $241.39 | EDGAR |
| 2026-08-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-06-17 | 4 | Zenas BioPharma, Inc. (ZBIO) | Grant/award (A): 18,500 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | BioAge Labs, Inc. (BIOA) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Vera Therapeutics, Inc. (VERA) | Grant/award (A): 17,084 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | RAPID MICRO BIOSYSTEMS, INC. (RPID) jointly with Longitude Capital Partners II, LLC, Longitude Venture Partners II, L.P., Longitude Prime Partners, LLC, Longitude Prime Fund, L.P., Tammenoms Bakker Juliet | Sale (S): 49,000 @ $3.88 | EDGAR |
| 2026-02-05 | 4 | Veradermics, Inc (MANE) | Conversion (C): 1,236,631 · Conversion (C): 1,171,121 · Conversion (C): 1,171,121 · Purchase (P): 192,647 @ $17 · Purchase (P): 882,353 @ $17 · Conversion (C): 1,236,631 (derivative) · +3 more | EDGAR |
| 2026-02-03 | 4 | RAPID MICRO BIOSYSTEMS, INC. (RPID) jointly with Longitude Capital Partners II, LLC, Longitude Venture Partners II, L.P., Longitude Prime Partners, LLC, Tammenoms Bakker Juliet | Option exercise/expiry (X): 629,032 @ $0.05 · Sale (S): 7,739 @ $4.06 · Sale (S): 46,000 @ $4.54 · Sale (S): 27,500 @ $4.25 · Sale (S): 27,500 @ $4.24 · Option exercise/expiry (X): 500,000 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-08 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Other (J): 5,000 @ $0 | EDGAR |
| 2025-12-15 | 4 | Vera Therapeutics, Inc. (VERA) | Purchase (P): 5,882 @ $42.50 | EDGAR |
| 2025-10-14 | 4 | Zenas BioPharma, Inc. (ZBIO) | Purchase (P): 105,265 @ $19 · Purchase (P): 11,990 @ $20.85 | EDGAR |
| 2025-08-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 3,507 @ $0 · Tax withholding (F): 1,805 @ $111.25 | EDGAR |
| 2025-06-25 | 4 | Vera Therapeutics, Inc. (VERA) | Purchase (P): 69,798 @ $20.87 · Purchase (P): 139,595 @ $20.87 · Purchase (P): 13,536 @ $22.35 · Purchase (P): 27,071 @ $22.35 | EDGAR |
| 2025-06-12 | 4 | Zenas BioPharma, Inc. (ZBIO) | Grant/award (A): 18,500 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | BioAge Labs, Inc. (BIOA) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Vera Therapeutics, Inc. (VERA) | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2024-09-27 | 4 | BioAge Labs, Inc. (BIOA) | Conversion (C): 1,310,589 · Purchase (P): 400,000 @ $18 · Grant/award (A): 15,000 (derivative) @ $0 · Conversion (C): 5,848,637 (derivative) | EDGAR |
| 2024-09-16 | 4 | Zenas BioPharma, Inc. (ZBIO) | Conversion (C): 723,812 · Conversion (C): 1,003,592 · Conversion (C): 334,530 · Purchase (P): 440,000 @ $17 · Conversion (C): 6,284,933 (derivative) · Conversion (C): 8,714,293 (derivative) · +2 more | EDGAR |
| 2024-08-06 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 3,731 @ $0 | EDGAR |
| 2024-05-17 | 4 | Vera Therapeutics, Inc. (VERA) | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1253886 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →